Literature DB >> 6402060

Long-term continuous intraperitoneal insulin treatment in brittle diabetes.

G Pozza, D Spotti, P Micossi, M Cristallo, M Melandri, P M Piatti, L D Monti, A E Pontiroli.   

Abstract

Attempts to achieve a fair metabolic equilibrium in a young woman with brittle diabetes by continuous subcutaneous, intramuscular, and continuous intravenous administration of insulin were unsuccessful. Continuous intraperitoneal administration of insulin through a permanently inserted polyethylene catheter connected to an open-loop peristaltic pump led to an appreciable improvement in mean blood glucose concentration, mean amplitude of glycaemic excursions, and M value and to normalisation of intermediate metabolic products. The peritoneal catheter was well tolerated for over 120 days without appreciable adverse effects. This case suggests that long-term intraperitoneal administration of insulin is a feasible therapeutic approach in the management of brittle diabetes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6402060      PMCID: PMC1546467          DOI: 10.1136/bmj.286.6361.255

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  3 in total

1.  THE M-VALVE, AN INDEX OF BLOOD-SUGAR CONTROL IN DIABETICS.

Authors:  J SCHLICHTKRULL; O MUNCK; M JERSILD
Journal:  Acta Med Scand       Date:  1965-01

2.  Mean amplitude of glycemic excursions, a measure of diabetic instability.

Authors:  F J Service; G D Molnar; J W Rosevear; E Ackerman; L C Gatewood; W F Taylor
Journal:  Diabetes       Date:  1970-09       Impact factor: 9.461

3.  Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption.

Authors:  J C Pickup; P D Home; R W Bilous; H Keen; K G Alberti
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-31
  3 in total
  8 in total

1.  Drug delivery by program or sensor controlled infusion devices.

Authors:  M Franetzki
Journal:  Pharm Res       Date:  1984-11       Impact factor: 4.200

2.  Brittle diabetes--present concepts.

Authors:  G V Gill; S Walford; K G Alberti
Journal:  Diabetologia       Date:  1985-08       Impact factor: 10.122

3.  Management of "brittle" diabetes with a preprogrammable implanted insulin pump delivering intraperitoneal insulin.

Authors:  D F Wood; K Goodchild; P Guillou; D J Thomas; D G Johnston
Journal:  BMJ       Date:  1990-11-17

4.  Realizing a Closed-Loop (Artificial Pancreas) System for the Treatment of Type 1 Diabetes.

Authors:  Rayhan A Lal; Laya Ekhlaspour; Korey Hood; Bruce Buckingham
Journal:  Endocr Rev       Date:  2019-12-01       Impact factor: 19.871

5.  Metabolic instability in type I diabetic patients. Studies on insulin absorption, hepatic production of metabolites and glucose counterregulation.

Authors:  P Micossi; M Scavini; F Dosio; L Monti; P M Piatti
Journal:  Acta Diabetol Lat       Date:  1985 Jul-Sep

6.  Metabolic control of type I (insulin dependent) diabetes after pancreas transplantation.

Authors:  G Pozza; E Bosi; A Secchi; P M Piatti; J L Touraine; A Gelet; A E Pontiroli; J M Dubernard; J Traeger
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-24

7.  Chronic continuous intraperitoneal insulin infusion (CIPII) in type I diabetic patients non-satisfactorily responsive to continuous subcutaneous insulin infusion (CSII).

Authors:  P Micossi; E Bosi; M Cristallo; L D Monti; M C Librenti; G Petrella; G Galimberti; D Spotti; G Giudici; C Vergani
Journal:  Acta Diabetol Lat       Date:  1986 Apr-Jun

8.  Adipocyte insulin binding and insulin sensitivity in 'brittle' diabetes.

Authors:  R Taylor; D J Husband; S M Marshall; W M Tunbridge; K G Alberti
Journal:  Diabetologia       Date:  1984-10       Impact factor: 10.122

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.